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Abstract
Background: Semliki Forest virus (SFV) has a positive strand RNA genome and infects different
cells of vertebrates and invertebrates. The 5' two-thirds of the genome encodes non-structural
proteins that are required for virus replication and synthesis of subgenomic (SG) mRNA for
structural proteins. SG-mRNA is generated by internal initiation at the SG-promoter that is located
at the complementary minus-strand template. Different types of expression systems including
replication-competent vectors, which represent alphavirus genomes with inserted expression
units, have been developed. The replication-competent vectors represent useful tools for studying
alphaviruses and have potential therapeutic applications. In both cases, the properties of the vector,
such as its genetic stability and expression level of the protein of interest, are important.
Results: We analysed 14 candidates of replication-competent vectors based on the genome of an
SFV4 isolate that contained a duplicated SG promoter or an internal ribosomal entry site (IRES)-
element controlled marker gene. It was found that the IRES elements and the minimal -21 to +5
SG promoter were non-functional in the context of these vectors. The efficient SG promoters
contained at least 26 residues upstream of the start site of SG mRNA. The insertion site of the SG
promoter and its length affected the genetic stability of the vectors, which was always higher when
the SG promoter was inserted downstream of the coding region for structural proteins. The
stability also depended on the conditions used for vector propagation. A procedure based on the
in vitro transcription of ligation products was used for generation of replication-competent vector-
based expression libraries that contained hundreds of thousands of different genomes, and
maintained genetic diversity and the ability to express inserted genes over five passages in cell
culture.
Conclusion: The properties of replication-competent vectors of alphaviruses depend on the
details of their construction. In the case of SFV4, such vectors should contain the SG promoter
with structural characteristics for this isolate. The main factor for instability of SFV4-based
replication-competent vectors was the deletion of genes of interest, since the resulting shorter
genomes had a growth advantage over the original vector.
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Background
The alphavirus (family Togaviridae) genome is a positive-
stranded RNA that is approximately 11.5 kb in length. It
encodes two large polyprotein precursors that are co- and
post-translationally processed into active processing inter-
mediates and mature proteins [1]. The structural proteins,
encoded by the 3' one-third of the genome, are translated
from a subgenomic (SG) mRNA, which is generated by
internal initiation from the SG promoter that is located on
the complementary minus-strand template. The non-
structural (ns) polyprotein is translated directly from the
viral genomic RNA. It is processed into individual compo-
nents, the ns proteins nsP1–nsP4. The nsPs have multiple
enzymatic and non-enzymatic functions required in viral
RNA replication [2]. Semliki Forest virus (SFV), Sindbis
virus (SINV) and Venezuelan equine encephalitis virus
(VEEV) are the best studied alphaviruses, and have also
been used for the development of gene expression systems
[3-5].
Alphavirus-based expression vectors have been classified
into three groups: virus-like particles (VLPs), layered
DNA-RNA vectors, and replication-competent vectors [6].
VLPs are produced by co-transfection of cells with an in-
vitro-transcribed replicon RNA, which represents the
alphavirus genome in which the region coding for struc-
tural proteins has been replaced by a gene of interest and
a helper RNA encoding for structural proteins [3,7]. In
VLP-infected cells, a high level of synthesis of foreign pro-
teins takes place, and at the same time, the system is self-
limiting because helper-RNAs are not encapsidated. Lay-
ered DNA-RNA vectors represent systems where the cDNA
of a replicon vector is flanked with eukaryotic transcrip-
tion elements, with a promoter at the 5'-end and a
poly(A) signal at the 3' end. Layered systems can be used
for VLP production; however, more often, they are used
for rescue of alphavirus replicons and subsequent protein
expression in transfected cells [8-11]. Layered systems
have been used to rescue alphavirus genomes in trans-
fected cells [12,13], but so far, not for construction and
rescue of replication-competent alphavirus-based vectors.
The replication-competent alphavirus vectors are
designed to undergo several rounds of multiplication in
cell culture or in hosts. Several approaches have been used
for construction of such vectors. First, foreign gene or
genes can be inserted in selected position(s) in ns-poly-
protein in a way that it is expressed in form of a fusion-
protein together with some alphavirus ns-protein [14-16].
Such vectors express the foreign protein at early stages of
infection. Second, a protein can also be expressed as cleav-
able part of an alphavirus-encoded structural or ns poly-
protein [17-19]. Third, the number of expression units in
a vector can be increased by inserting duplicated copies of
SG promoters into the alphavirus genome, either in the 3'-
untranslated region (UTR) or into the short intergenic
region between the ns and structural regions [20-23]. Such
vectors have served as useful instruments for analysis of
the structure, function and evolution of SG promoters
[20,24-27] and for the analysis of viral movement in
infected organisms [28]. Some of these vectors have been
used as tools for foreign protein expression [21]. Replica-
tion-competent vectors have also been used for cloning
and analysis of libraries generated by random or insertion
mutagenesis [15,16,25-27], and the use of such vectors for
therapeutic and prophylactic applications has also been
proposed [6]. In addition to the duplication of SG pro-
moters, the expression of a foreign gene by using an inter-
nal ribosomal entry site (IRES) has been described for
alphavirus VLPs [29], DNA-RNA layered vectors [30], and
replication-competent vectors based on rubella virus,
another member of the Togaviridae family [31]. The IRES
element has also been utilized to develop VEEV variants
incapable of replication in mosquito cells [32].
The increase in the genome size of the vector caused by
duplications of viral sequences and/or gene insertion
slows down its replication, which can cause problems
with regulation of gene expression and packaging of
larger-than-normal genomes into icosahedral capsids.
Therefore, the intrinsic problem for such vectors is their
genetic instability, which results from the lack of proof-
reading ability of alphavirus RNA polymerases and spon-
taneous recombination in the vector genome [17-
19,23,31,33]. It has been reported that the site and mode
of the marker gene insertion [15,16,18], the positioning
of duplicated SG promoter [23], the host and conditions
used for vector propagation [19,23], as well as the nature
of the inserted gene itself (our unpublished observations)
all affect the stability of replication-competent alphavirus
vectors.
Expression of the protein of interest as part of a structural
or ns polyprotein strictly links the time and level of its
expression with those of the corresponding viral proteins.
In addition, the requirement to maintain the reading
frames of the structural or ns polyproteins complicates the
cloning procedure and severely hampers the usage of such
vectors for cloning expression libraries. These problems
do not exist for vectors with duplicated SG promoters
such as the SFV-based vector VA7. Despite its low genetic
stability, this vector has been successfully used for various
applications [22,34-36].
For construction of efficient and stable vectors with dupli-
cated SG promoters, information about the structure and
function of this element is essential. The SG promoter of
SINV has been studied extensively for almost two decades.
Its minimal sequence consists of 24 residues located from
-19 to +5 with respect of the start site of SG mRNA (here-Virology Journal 2009, 6:33 http://www.virologyj.com/content/6/1/33
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after, SG promoters are designated as 19/5 etc.), and it is
approximately 3–6-fold less active than a full-size SG pro-
moter (98/14 or 40/14) of SINV [20,27,37]. In addition,
molecular interactions between the replicase of SINV and
its SG promoter sequences have been studied [38-40], and
specific mechanisms involved in the initiation of transla-
tion of SG mRNA have been analysed [41-43]. Much less
is known about the SG promoter of SFV. It has been
reported that the minimal SG promoter of some SFV iso-
lates (sequence published in [44]), but not that of isolate
SFV4 (sequence published in [45]), is active in the context
of replication-competent vectors of SINV. This difference
has been attributed to the unusual G residue at the -1 posi-
tion of the SG promoter of SFV4 (most alphaviruses have
an A residue at this position). It has been hypothesized
that, in the context of the native genome of SFV4, the
effect of the -1 G residue might be compensated by some
other changes [24].
The aim of the present study was to obtain genetically sta-
ble SFV4-based replication-competent vectors that can
also be used for construction of expression libraries. It was
found that the SFV4 vectors with a duplicated SG pro-
moter placed at the 3'-UTR were invariably more stable
than those containing similar duplications in the inter-
genic region. The inserted IRES elements were found to be
non-functional in the context of replication-competent
SFV4 vectors. A novel approach, based on in vitro tran-
scription of ligation products, which allowed conversion
of a replicon vector into a replication-competent vector
and cloning of expression libraries, was developed.
Results
Construction and viability of SFV4-based replication-
competent vectors with duplicated SG promoters
We have previously observed, using the SFV-based VLP
system, that expression of the protein of interest from a
short 20/6 SG promoter of SFV4 was considerably weaker
than that from different IRES elements [29]. This indicates
that the minimal SG promoter for SFV4 is likely to be
longer than the minimal 19/5 SG promoter for SINV.
Therefore, two sets of vectors with duplicated SG promot-
ers, each consisting of four different constructs, were
made and tested for their ability to express SFV4 ns pro-
teins (exemplified by nsP1), structural proteins (exempli-
fied by capsid protein) and inserted marker protein
(destabilized EGFP, d1EGFP).
Terminal (T) vectors were designated as SFV4-T21/5-
d1EGFP, SFV4-T26/20-d1EGFP, SFV4-T37/17-d1EGFP
and SFV4-T99/45-d1EGFP. They contained the indicated
SG promoter and d1EGFP insertion immediately down-
stream of the termination codon for E1 protein (Figure 1A
and 1B). Middle (M) vectors were designated as SFV4-
d1EGFP-M96, SFV4-d1EGFP-M37, SFV4-d1EGFP-M26
and SFV4-d1EGFP-M21. In the middle vectors, the expres-
sion of inserted d1EGFP marker was derived from native
ns/30 SG promoter of SFV4, while the expression of viral
Sequence of SG promoter region and schematic presentation  of SFV4-based replication-competent vectors Figure 1
Sequence of SG promoter region and schematic 
presentation of SFV4-based replication-competent 
vectors. (A) Sequence of SG region of SFV4 (in positive 
strand) from position -100 to 60. Arrow indicates start site 
of SG mRNA, short conserved sequence element of SG pro-
moters of alphaviruses (-35 to -30), unique -1 G residue of 
SG promoter of SFV4, termination codon for ns-polyprotein 
reading frame (11 to 13), and initiation codon for structural 
polyprotein (52 to 54) are shown in color. (B) Schematic 
presentation of the genomes of replication-competent SFV4-
based vectors. "Middle1" represents genomes of middle vec-
tors rescued by use of infectious in vitro transcripts and 
"Middle2" represents genomes of middle vectors rescued 
from infectious plasmid by cellular RNA synthesis and splicing 
machinery. Arrows indicate SG promoters, and UTR-(A)n 
indicates 3'-UTR of SFV4 with poly(A) sequence. The struc-
ture of SG promoters is shown below the drawing, "wt" indi-
cates the native SG promoter of SFV4 and "ns/30" indicates 
the native SG promoter with truncated downstream region 
(residues 31 to 51 are deleted). HRP- on structural protein 
indicates the destabilized capsid hairpin element.Virology Journal 2009, 6:33 http://www.virologyj.com/content/6/1/33
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structural proteins was achieved by a duplicated SG pro-
moter (Figure 1A and 1B). All duplicated SG promoters in
middle vectors were designed to produce SG mRNA with
a full-length (51 b) leader sequence, since it has been
reported that extensive deletions in the 3'-region of the SG
mRNA leader sequence of SINV reduce the translation of
downstream regions by two-fold or more [42]. With that
exception, the two sets of vectors contained duplicated SG
promoters of comparable composition.
To analyse the functionality of constructed vectors, BHK-
21 cells were transfected with infectious transcripts pre-
pared from all eight constructs, and the transcripts from
pSP6-SFV4 [46] were used as a control. The efficiency of
the transfection procedure was reproducibly close to
100% (data not shown). The analysis revealed that, as
expected, all vectors expressed nsP1 at comparable levels
(Figure 2), which indicated efficient replication in trans-
fected cells. In contrast, the level of d1EGFP expression
was different: no d1EGFP expression was detected by
immunoblotting (Figure 2) or by fluorescent microscopy
in SFV4-T21/5-d1EGFP transfected cells, and only very
faint d1EGFP expression was detected for this vector by
use of flow cytometry (data not shown). At the same time,
d1EGFP expression was detected clearly in cells trans-
fected by other vectors. For terminal vectors, the highest
level of d1EGFP expression was detected in SFV4-T99/45-
d1EGFP-transfected cells, while the d1EGFP levels for
SFV4-T26/20-d1EGFP and SFV4-T37/17-d1EGFP were
lower and similar to each other (Figure 2). Thus, in the
case of terminal vectors, the d1EGFP expression correlated
with length of duplicated SG promoter. In the case of all
middle vectors, the d1EGFP expression was derived from
identical SG promoters. Nevertheless, its expression levels
in transfected cells were not identical: a reverse correlation
between d1EGFP expression level and the length of dupli-
cated SG promoter was observed (Figure 2). This tendency
is similar to that previously observed in SINV vectors [20],
and most likely reflects the consequence of competition
between SG promoters placed close to each other.
With the notable exception of SFV4-d1EGFP-M21, all rep-
lication-competent vectors with duplicated SG promoters
produced capsid protein at a level similar to that for SFV4
(Figure 2). The growth kinetics of these vectors in trans-
fected cell culture were similar to those of SFV4 (data not
shown), and the titres of collected stocks reached 2 × 108–
5 × 108 pfu/ml at 12 h post-transfection. In SFV4-d1EGFP-
M21-transfected cells, the levels of capsid protein were sig-
nificantly lower (Figure 2), the release of infectious viri-
ons into the growth medium was delayed by 4 h, and the
virus titre at 12 h post-transfection was approximately
100-fold lower than that for other vectors. In addition,
very few (<1%) of the cells infected at multiplicity of
infection (moi) of 1 with collected stock of SFV4-d1EGFP-
M21 were d1EGFP-positive. Taken together, these data
indicated that both 21/5 and 21/51 SG promoters were
not functional (or had extremely low activity) in their
native context. Therefore, SFV4-d1EGFP-M21 was able to
replicate its RNA but not to produce structural proteins
and consequently to form infectious virions. This resulted
in huge selection pressure for re-positioning of the expres-
sion of the structural region under the control of an active
native SG promoter. The plasticity of the alphavirus
genomes allowed the required changes to take place very
rapidly; the 4-h delay, observed in virion formation for
SFV4-d1EGFP-M21, is in agreement with the time
required for SFV4 to accumulate compensatory changes
[47]. Thus, the capsid protein detected in SFV4-d1EGFP-
M21-transfected cells was most likely produced by recom-
binant genomes that have gained the ability to express
structural proteins and have lost the ability to express
d1EGFP. The easiest way to achieve this is the deletion of
the inserted sequence by copy-choice recombination
between native SG promoter sequences and its duplicated
copy, which, in the case of SFV4-d1EGFP-M21, shared an
identical region of 51 bases. It was confirmed by RT-PCR
Protein expression in BHK-21 cells transfected with replica- tion-competent vectors with duplicated SG promoters Figure 2
Protein expression in BHK-21 cells transfected with 
replication-competent vectors with duplicated SG 
promoters. BHK-21 cells were transfected with equal 
amount of in vitro transcripts prepared from pSFV4-T21/5-
d1EGFP, pSFV4-T26/20-d1EGFP, pSFV4-T37/17-d1EGFP, 
pSFV4-T99/45-d1EGFP, pSFV4-d1EGFP-M96, pSFV4-
d1EGFP-M37, pSFV4-d1EGFP-M26 and pSFV4-d1EGFP-M21; 
cells transfected with transcripts from pSP6-SFV4 were used 
as controls. Cells were collected at 12 h post-transfection, 
lysed in Laemmli buffer, and subjected to SDS-PAGE in 12% 
gel; each line corresponds to material from 50,000 cells. Pro-
teins were transferred to nitrocellulose filter, probed by cor-
responding polyclonal antisera, and visualized by ECL. 
Sections of the blots probed by anti-SFV-nsP1 antiserum 
(top), anti-EGFP antiserum (middle) and anti-SFV-capsid 
antiserum (bottom) are shown. The bands corresponding to 
detected proteins are indicated with arrows on the left; the 
names of replication-competent vectors are shown above 
the blot. SFV4 indicates cells transfected with infectious tran-
scripts from pSP6-SFV4.Virology Journal 2009, 6:33 http://www.virologyj.com/content/6/1/33
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and sequencing that exact deletion of inserted d1EGFP
and duplicated SG promoter had occurred already in
SFV4-d1EGFP-M21-transfected cells, and mutants carry-
ing such a deletion became dominant in the collected
stock (data not shown). However, it remains possible that
other mechanisms such as selection of compensatory
mutations may also have contributed to the activation of
structural protein expression.
Construction and viability of SFV4-based replication-
competent vectors with inserted IRES elements
The length and positioning of duplicated SG promoters in
the genome of the replication-competent vector allows
modulation of the level of expression of the protein of
interest (Figure 2). In contrast, the time of its expression is
strictly determined by the start of SG mRNA synthesis. The
IRES of encephalomyocarditis virus (EMCV) has been
shown previously to be functional in SINV-infected cells
[42], as well as in the context of DNA-RNA layered SINV
replicon vectors [30] and SFV VLP vectors [29]. In addi-
tion, an IRES element from crucifer-infecting tobamovirus
(CR IRES) is also functional in SFV VLP systems [29].
Thus, the use of IRES elements in replication-competent
alphavirus vectors represents an attractive option for early
and efficient expression of the gene of interest. Neverthe-
less, with the exception of construction of vertebrate-spe-
cific VEEV genomes [32], their use in replication-
competent alphavirus vectors has not been described.
To test such possibility, we first constructed vectors where
EMCV IRES or CR IRES with d1EGFP marker were inserted
into the 3'-UTR of SFV4 (Figure 1B). In transfected cells,
these vectors, designated SFV4-EMCV-d1EGFP and SFV4-
CR-d1EGFP, expressed normal levels of nsP1 (for some
unknown reason, SFV4-CR-d1EGFP expressed more nsP1
than did SFV4-EMCV-d1EGFP) and capsid protein (Figure
3). The growth kinetics and the final titres of collected
stocks were both similar to those of SFV4 (data not
shown). At the same time, no expression of d1EGFP was
detectable by any method including fluorescent micros-
copy, flow cytometry (data not shown) or immunoblot-
ting (Figure 3).
In order to verify if the observed lack of d1EGFP expres-
sion was the consequence of positioning IRES elements
downstream of structural region of SFV4, the vectors des-
ignated as SFV4-d1EGFP-MEMCV and SFV4-d1EGFP-
MCR (Figure 1B) were constructed and analysed. In trans-
fected cells, efficient expression of nsP1 and d1EGFP
marker was detected (Figure 3). At the same time, the
expression of capsid protein (Figure 3), growth kinetics
and titres of collected viral stocks were reminiscent of
those of SFV4-d1EGFP-M21, except that capsid protein
expression, and consequently, the titres of collected stocks
(approximately 1×104–4×104 pfu/ml) were even lower.
Thus, the IRES elements were also not functional in the
intergenic region of replication-competent SFV4-based
vectors. The expression of structural proteins was restored
in SFV4-d1EGFP-MEMCV- and SFV4-d1EGFP-MCR-trans-
fected cells by deletion of inserted sequences; however, in
these cases, the deletion was less efficient than for SFV4-
d1EGFP-M21. The most likely explanation for this is that,
unlike SFV4-d1EGFP-M21, SFV4-d1EGFP-MEMCV and
SFV4-d1EGFP-MCR do not contain duplicated sequences,
which excludes the possibility of deletion by a homolo-
gous copy-choice recombination mechanism.
The lack of detectable IRES-derived marker expression in
the case of SFV4-d1EGFP-MEMCV and SFV4-d1EGFP-
MCR could not be attributed to the position of IRES with
respect to the native SG promoter, the length of spacer
between these two elements, or to the positioning of the
start codon of the downstream ORF with respect to the
IRES, since all these parameters were identical to the pre-
viously used SFV VLP systems [29]. The only difference
was the sequence, placed under the control of IRES ele-
ments, which was the structural region of SFV4 instead of
bcl2 or hcRed in previously described VLP vectors. There
were significant differences between those sequences in
terms of length and their secondary structure. Only the
secondary structure of the structural region can be modi-
fied in replication-competent vectors. Notably, the RNA
region, which encodes for the first 31 N-terminal amino
acid residues of the capsid protein, forms a strong hairpin
Protein expression in BHK-21 cells transfected with replica- tion-competent vectors containing inserted IRES elements Figure 3
Protein expression in BHK-21 cells transfected with 
replication-competent vectors containing inserted 
IRES elements. BHK-21 cells were transfected with equal 
amount of in vitro transcripts prepared from pSFV4-EMCV-
d1EGFP, pSFV4-CR-d1EGFP, pSFV4-d1EGFP-MEMCV and 
pSFV4-d1EGFP-MCR, and cells transfected with transcripts 
from pSP6-SFV4 were used as controls. Analysis was carried 
out and materials are presented as described in Figure 2.Virology Journal 2009, 6:33 http://www.virologyj.com/content/6/1/33
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structure. Since the hairpin in alphavirus SG mRNA and
IRES elements are used by viruses to ensure the translation
of their mRNAs in cells in which translation of cellular
messages has stopped [41], they may interfere with each
other. To test that possibility, the secondary structure of
SFV4 capsid hairpin was destabilized by introducing 24
silent mutations into a 93-bp region. These changes
resulted in a decrease of predicted minimum free energy
for the corresponding fragment of RNA molecule from -
40.2 to -11.74 kcal/mol (prediction made by Vienna RNA
package RNAfold Webserver software; http://rna.tbi.uni
vie.ac.at/cgi-bin/RNAfold.cgi), and by analogy with simi-
lar manipulation made in the context of the SINV genome
[41], should eliminate the functioning of this element in
non-typical translation initiation. Destabilization of the
capsid hairpin structure greatly increased the intrinsic
instability of pSP6-SFV4 plasmid-based constructs, most
likely because it enhanced the translation of toxic struc-
tural proteins of SFV4 in Escherichia coli. To overcome this
problem, all corresponding elements were transferred to
pCMV-SFV4 [13], and the resulting infectious plasmids
were designated pCMV-SFV4-d1EGFP-MEMCV-HRP- and
pCMV-SFV4-d1EGFP-MCR-HRP-(replicating vectors,
released from these plasmids, are shown in Figure 1B as
Middle2 vectors). When transfected into BHK-21 cells,
both plasmids were capable of initiating replication of the
vector and d1EGFP expression (data not shown); how-
ever, in contrast to pCMV-SFV4, they produced an
extremely low amount of capsid protein and infectious
virus. Therefore, it was concluded that the destabilization
of capsid hairpin structure did not result in activation of
IRES function.
Multiplication and RNA synthesis of the replication-
competent SFV vectors
The nine replication-competent vectors constructed in
this study produced infectious progeny, which, upon re-
infection of BHK-21 cells, reproduced the properties of
the original in vitro transcripts. Their ability to replicate in
BHK-21 cells was analysed by two different methods.
First, growth curves for these vectors were built and ana-
lysed (Figure 4). The growth curves of all replication-com-
petent vectors were similar to each other, and their titres
observed 12 h post-infection were somewhat reduced in
comparison to those of parental SFV4. These properties
are similar to those of other SFV vectors that contain an
EGFP insertion [18], and may represent a consequence of
increased genome sizes. In general, vectors that contained
the largest duplicated SG promoters or IRES elements
exhibited slightly slower growth and 2–3-fold lower final
titres than vectors with smaller duplicated SG promoters.
At the same time, no clear differences between the termi-
nal and middle vectors that contained duplicated SG pro-
moters of the same type (-26, -37 or the largest SG
promoter) were observed (Figure 4).
Second, the accumulation of viral RNAs in infected BHK-
21 cells was analysed by Northern blotting. This analysis
revealed that all replication-competent vectors produced
genomic RNAs and SG mRNAs with the expected size. No
major additional RNA species were detected for these vec-
tors, which indicated that the passage 1 (P1) stocks used
for this experiment were homogeneous (Figure 5). The
amount of genomic RNA produced by the constructed
vectors was comparable to that of parental SFV4, except
that, for SFV4-d1EGFP-M37 and SFV4-d1EGFP-M26,
some reduction in the amount genomic RNA (as well as
SG mRNAs) was detected. As expected, vectors that con-
tained a duplicated SG promoter produced two SG
mRNAs (Figure 5). The exception to this was SFV4-T21/5-
d1EGFP, for which a second SG mRNA was not detected,
even with prolonged exposition of the blot (data not
shown). Thus, it was again confirmed that, in contrast to
the 19/5 SG-promoter of SINV, the 21/5 SG-promoter of
SFV4 was extremely weak. Expectedly, SFV4-EMCV-
d1EGFP and SFV4-CR-d1EGFP produced only a single SG
mRNA and, judged by the size, the IRES-d1EGFP insertion
was maintained.
Growth curves of replication-competent SFV4 vectors Figure 4
Growth curves of replication-competent SFV4 vec-
tors. BHK-21 cells were infected with P1 stocks of SFV4-
T21/5-d1EGFP, SFV4-T26/20-d1EGFP, SFV4-T37/17-d1EGFP, 
SFV4-T99/45-d1EGFP, SFV4-d1EGFP-M26, pSFV4-d1EGFP-
M37, pSFV4-d1EGFP-M96, SFV4-EMCV-d1EGFP, SFV4-CR-
d1EGFP or SFV4 at an moi of 0.1. Aliquots of culture medium 
were collected at 2, 4, 6, 10 and 12 h post-infection, and the 
amount of virus in aliquots was analyzed by plaque titration. 
The colour and symbols used to present the growth curve of 
each vector are shown below the figure. Results from one 
reproducible experiment are presented for clarity.
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Genetic stability of replication-competent SFV4-based 
vectors
In order to be useful, the replication-competent vector
must maintain its ability to express the gene of interest
over several generations. Accumulation of point muta-
tions in inserted sequences caused by the high error rate of
RNA polymerases depends on the length of the inserted
sequence and not on the design of the vector. At the same
time, this process does not result in an increase in
genomes with significant growth advantages over the orig-
inal replication-competent vector. Therefore deletions of
the inserted sequences, which results in at least three
important advantages for the mutated genome, are the
main factor that reduces genetic stability of the vector.
Namely: (i) smaller sizes facilitate packaging of the
genome; (ii) elimination of inserted expression units
restores the wild-type regulation and coordination of viral
RNA and protein synthesis; and (iii) shorter genomes can
replicate faster. Thus, wild-type-like virus that can produce
up to 10-fold more infectious progeny (Figure 4) is capa-
ble of superseding the original replication-competent vec-
tor. The efficiency of this process depends on the
conditions of virus propagation. In the case of high moi,
the competition takes place only inside the infected cells,
and under these conditions, the high molar excess of orig-
inal vector genomes reduces the growth advantage of the
deletion mutants. In contrast, low moi involves spreading
of the infection in cell culture and therefore strongly
favours wild-type-like sequences.
These considerations were experimentally verified by the
use of a set from six replication-competent vectors. In the
first experiment, SFV4-T26/20-d1EGFP, SFV4-T37/17-
d1EGFP and SFV4-T99/45-EGFP were propagated five
times at an moi of 10 in BHK-21 cells, and the percentage
of d1EGFP-positive cells in each passage was measured by
flow cytometry. All cells infected with corresponding P5
stocks were found to be d1EGFP-positive (e.g., they were
infected by at least one particle capable of initiating
d1EGFP expression) (data not shown). In the second
experiment, in which the stability analysis was carried out
at low moi [18,19,23], clear differences in stability of rep-
lication-competent vectors were revealed (Table 1). Since
the d1EGFP fluorescence in infected cells was transient
and relatively weak, genome stability of the replication-
competent vectors was also analysed by RT-PCR. Results
of RT-PCR analysis were highly coherent with those pre-
sented in Table 1 and revealed that the decrease in the per-
centage of d1EGFP-positive plaques correlated with the
percentage of genomes with deletion of the inserted
Accumulation of viral RNA in BHK-21 cells infected with  replication-competent vectors Figure 5
Accumulation of viral RNA in BHK-21 cells infected 
with replication-competent vectors. BHK-21 cells were 
infected with P1 stocks of SFV4-T21/5-d1EGFP, SFV4-T26/
20-d1EGFP, SFV4-T37/17-d1EGFP, SFV4-T99/45-d1EGFP, 
SFV4-d1EGFP-M26, pSFV4-d1EGFP-M37, pSFV4-d1EGFP-
M96, SFV4-EMCV-d1EGFP, SFV4-CR-d1EGFP or SFV4 at an 
moi of 5. Control cells were mock-infected. Cells were har-
vested at 12 h post-infection. Total RNA was purified by TRI-
zol reagent and subjected to agarose electrophoresis and 
Northern blotting (10 μg total RNA per line). Letters and 
arrows on the left indicate positions of genomic RNA of vec-
tor or virus (A); SG mRNA expressed from native SG pro-
moter (B, except for SFV4 where this mRNA is indicated 
with an asterisk); SG mRNA expressed from duplicated SG-
promoter in middle (C) and terminal (D) vectors. The names 
of replication-competent vectors are shown above the blot. 
SFV4 indicates control cells infected with parental SFV4; neg. 
control indicates RNA from mock-infected cells.
Table 1: Comparison of genetic stability of different replication-
competent SFV4-based vectors in BHK-21 cells
P1 P2 P3 P4 P5
SFV4-T37/17-d1EGFP 100% 100% 100% 80% 70%
SFV4-T26/20-d1EGFP 100% 96% 85% 59% 41%
SFV4-T99/45-d1EGFP 96% 75% 65% 41% 15%
SFV4-d1EGFP-M26 100% 50% 11% 0% 0%
SFV4-d1EGFP-M37 9 6 %6 4 %3 8 %3 %0 %
SFV4-d1EGFP-M96 96% 50% 19% 11% 0%
The d1EGFP expression was transient and relatively weak. Therefore, 
it is possible that some d1EGFP positive plaques were counted as 
d1EGFP negative and the stability of constructs was somewhat under-
estimated.Virology Journal 2009, 6:33 http://www.virologyj.com/content/6/1/33
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marker (data not shown). The main conclusion from this
experiment is that all terminal vectors of SFV4 were more
stable than their middle vector counterparts. The differ-
ences could not be attributed to differences in growth
properties (Figure 4); instead, they may have originated
from the different outcome of homologous copy-choice
recombination. In the case of middle vectors, the homol-
ogous recombination between native and duplicated SG
promoters resulted in re-creation of the wild-type SFV4
genome. In the case of terminal vectors, the same process
resulted in deletion of the structural region. It can be seen
that, at least for terminal vectors, the vectors with shorter
duplicated SG promoters were more stable than those that
contained the longest duplicated SG promoter. The most
likely reason for this was the slower growth rate of the lat-
ter (Figure 4), which increased growth advantage of dele-
tion mutants over the original vector genomes.
In vitro ligation/transcription for construction of 
replication-competent SFV vectors and libraries, based on 
these vectors
The plasmid for infectious cDNA of SFV4, pSP6-SFV4 is
unstable in E. coli cells. This property is maintained or
even enhanced for plasmids that contain cDNAs of repli-
cation-competent vectors. To overcome this problem, we
have previously developed a stable pCMV-SFV4 plasmid,
which can be used for construction of SFV replication-
competent vectors. However, its infectivity is lower than
that for infectious transcripts [13], especially in cells in
which the CMV promoter is weak. Thus, pCMV-SFV4 rep-
resents a useful alternative to pSP6-SFV4, but has limita-
tions of its own.
In contrast to pSP6-SFV4, pSFV1 and pHelper1 are stable
in E. coli and this property is preserved in the majority of
constructs based on these plasmids. Thus, if the elements
required for foreign gene expression are included in one
of derivatives of these plasmids, it may be possible to
rejoin it with another part of the SFV4 genome and use the
resulting molecule directly for in vitro transcription. One
possibility to achieve this is to use PCR. Unfortunately,
PCR always lead to generation of a pool of heterogeneous
sequences that contain random PCR mutations, which
can have unpredictable effects on the properties of the
replication-competent vectors. Therefore, instead of using
PCR, we designed vectors in which a unique ApaI restric-
tion site was located downstream of d1EGFP in pSFV1-
PLApa-d1EGFP -and upstream of duplicated SG promoter
in pHelper96, pHelper37, pHelper26 and pHelper21. The
fragment that contained the SP6 promoter, the ns region
of SFV4 and d1EGFP was cut out from pSFV1-PLApa-
d1EGFP by SphI/ApaI restriction and ligated to the ApaI/
SpeI fragment from pHelper96 that contained a dupli-
cated SG promoter, structural region, and a 3'-UTR with
the poly(A) of SFV4 (Figure 6A). The products of the liga-
tion reaction were transcribed in vitro and, since only the
transcript corresponding to the genome of the replication-
competent vector contained all the elements needed for
initiation of replication, the mixture was directly used to
transfect BHK-21 cells. Analysis of transfected cells by flu-
orescent microscopy revealed that d1EGFP expression and
replication were initiated in a large number of cells. By 24
h post-transfection, all cells showed the symptoms of
infection and the collected virus stock had a titre and
properties similar to the stock obtained from cells trans-
fected by transcripts from pSFV4-d1EGFP-M96. Thus, the
in vitro ligation/transcription procedure can be used for
construction of genomes of replication-competent SFV
vectors.
pSP6-SFV4-based libraries, propagated as a pool in E. coli,
are invariably and rapidly overgrown by bacteria contain-
ing defective plasmids. Therefore, another possible appli-
cation of the developed in vitro ligation/transcription
procedure is its usage for constructing SFV4 replication-
competent vector-based libraries. The first option for
doing this is to convert VLP-replicon libraries, generated
by the use of pSFV1-PLApa or similar vectors, to replica-
tion-competent vector libraries by the use of the above
approach. This will, however, result in replication-compe-
tent vectors that carry inserted sequences in the middle
position that, according to our data (Table 1), are rela-
tively unstable. Nevertheless, the approach can be used if
the vector instability is not a serious problem or it is over-
come by changes in vector design. The second option is to
generate libraries using terminal vectors. To demonstrate
the feasibility of this approach, 1 μg of the SphI/BamH1
restriction fragment from pSFV4-T37/17 vector was
ligated with a BamH1-digested PCR fragment that con-
tained a 21-bp randomized region, d1EGFP encoding
sequence, and a 3'-UTR and poly(A) tail of SFV4 (Figure
6B). The ligation product was transcribed in vitro and used
for transfection of BHK-21 cells. The number of initially
transfected cells (corresponding to the number of replica-
tion-competent vectors with different insertions in the
library) was measured by an infectious centre assay. After
the optimisation of DNA purification, ligation and tran-
scription procedures, libraries that contained 2×105–
5×105  different replication-competent vector genomes
were obtained per single in vitro ligation/transcription
procedure. These libraries were subsequently amplified to
high titre, propagated up to five times at an moi of 0.1,
and analysed again for their ability to express d1EGFP and
the presence of randomised sequences. The results of this
analysis confirmed that the inserted sequences were stable
in the pSFV4-T37/17-based library. Thus, the in vitro liga-
tion/transcription procedure can be used for construction
of large SFV replication-competent-vector-based expres-
sion libraries that can be subsequently propagated and
subjected to various analyses.Virology Journal 2009, 6:33 http://www.virologyj.com/content/6/1/33
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Discussion
In contrast to the minimal 19/5 SG-promoters of several
alphaviruses, the corresponding element of SFV4 has a G
residue at the -1 position of its sequence, and it is not
functional in the context of a replication-competent vec-
tor of SINV. It has been hypothesized that, under native
conditions, this change may be compensated by other
changes in the virus genome [24]. Indeed, it has been
shown that changes in cis-elements of alphaviruses can be
compensated by changes in replicase proteins and vice
versa [48,49]. The data presented above did not, however,
support this hypothesis, since the 21/5 SG promoter of
SFV4 had no detectable activity in the context of SFV4-
derived replication-competent vectors (Figure 5). Further-
more, the extreme instability of the SFV4-d1EGFP-M21
suggests that the even longer, 21/51 SG promoter of SFV4
was much less active than the minimal SG promoter of
SINV, which has been used in SINV vectors of analogous
design. Although the specific impact of the sequences
located downstream of the +5 position on the activity of
SFV4 SG promoter was not studied in detail, it is clear that
if these elements contributed to the activity of the SG-pro-
moter, their effect was rather small. Again, this differs
from the data obtained for SINV, in which the region
located between positions +6 and +14 significantly con-
tributes to the activity of SG promoters [27]. Thus, the
minimal SG promoter of SFV4 must contain more than 21
upstream residues. Three different regions upstream of the
Schematic presentation of the methods for replication-competent vector genome and library construction Figure 6
Schematic presentation of the methods for replication-competent vector genome and library construction. (A) 
Construction of replication-competent vector from restriction fragments of pSFV-PLApa-d1EGFP (SphI to ApaI) and 
pHelper96 (ApaI to SpeI). SP6 corresponds to the promoter for SP6 RNA polymerase; bold arrow indicates the ligation proc-
ess. (B) Construction of library from SphI/BamHI restriction fragment of pSFV4-T37/17 and BamHI-treated product of PCR-
based mutagenesis, which contained 21-bp randomized fragment, coding sequence of d1EGFP and SFV4 3'-UTR with poly(A). 
SP6 corresponds to the promoter for SP6 RNA polymerase and bold arrow indicates the ligation process. Symbols have the 
same meaning as in Figure 1B. Only the ligation products corresponding to the cDNAs of replication-competent vector (A) or 
replication-competent vector-based library (B) are shown.Virology Journal 2009, 6:33 http://www.virologyj.com/content/6/1/33
Page 10 of 16
(page number not for citation purposes)
+21 position were identified (Figure 1A): the -30/-35
region, which is conserved in SG promoters of alphavi-
ruses [27], and two non-conserved regions, located down-
stream (-29/-22) and upstream (ns/-36) of the conserved
element. The analysis of SG mRNA synthesis revealed that
T26/20, T37/17 and T99/45 SG promoters, as well as 26/
51, 37/51 and 96/51 SG promoters, were active and there
were no major differences in their activities (Figure 5).
Thus, the effect of the -1 G residue in the SG promoter of
SFV4 was compensated by the unique sequences located
in the -22 to -26 region.
The levels of SG mRNA produced by duplicated SG pro-
moters in SFV4-T99/45-d1EGFP- and SFV4-T26/20-
d1EGFP-infected cells were similar to each other (Figure
5), but d1EGFP expression was significantly higher in cells
transfected with the former construct (Figure 2). The most
likely explanation for this discrepancy is that the region
located between +21 and +45 had little or no effect on the
activity of SG promoter, but it did affect positively the
translation of corresponding SG mRNA, as has been
described for SINV SG promoter and SG mRNA [37,42].
The region between -96 and -27 had a small effect on tran-
scription activation (Figure 5). Since the detailed analysis
of SG mRNA synthesis was not in the scope of this study,
the exact significance of this region remains to be estab-
lished. Similarly, the precise mapping of the truly mini-
mal SG promoter of SFV4, estimation of its activity
relative to the full-size SG promoter, and identification of
the exact positions of critical residues that compensate for
the effect of the -1 G residue represent topics for further
studies.
The analysis of genetic stability of the constructed SFV4-
based replication-competent vectors (Table 1) revealed
that, in contrast to the related Chikungunya-virus-based
vectors [23], the terminal vectors of SFV4 were invariably
more stable than their middle-type counterparts. It is pos-
sible that the stability of replication-competent alphavirus
vectors may depend on their construction, for example,
from the exact position of duplicated elements and/or
from the genetic background of the vector itself. Our anal-
ysis also indicated that the loss of the ability to express a
functional gene of interest correlates with the loss of the
gene (or full expression unit), and is most likely caused by
gradual superseding of the original replication-competent
vector by its faster-growing deletion variants. Thus, the
stability of replication-competent vectors depends on the
frequency of formation of replication-competent
genomes with deletions and on their growth advantage
over the original vector. Both these factors may contribute
to the lower genetic stability of the middle vectors because
the homologous copy-choice recombination between SG
promoters results in the wild-type virus genome, which
has the biggest growth advantage over the replication-
competent vector. In the case of terminal vectors, only
non-homologous recombination events, which do not
result in reversion to exact wild-type genome, can take
place. However, other factors such as slightly larger sizes
of duplications, and stronger interference between native
and inserted elements cannot be excluded as reasons
behind lower stability of middle vectors.
The fact that the appearance of deletion variants of the
original vector and their subsequent increase in popula-
tion of replicating genomes are the most important factors
for vector instability suggests that conditions for propaga-
tion of replication-competent vectors must be carefully
selected. In contrast to the common practice with propa-
gation of viral stocks, when low moi is used to avoid an
increase in defective interfering (DI) genomes, the replica-
tion-competent vectors should be propagated under high
moi conditions. The deletion variants of replication-com-
petent vectors are, in contrast to DI genomes, fully compe-
tent for replication and particle production, and have an
increased growth advantage when the propagation
involves spreading in cell culture. Alternatively, the size of
sample used for vector propagation, should be reduced.
Our data on the stability of recombinant stocks (Table 1)
indicate that, in general, P1 stock contains less than 1%
defective vectors. Northern blot analysis revealed the
same (Figure 5), which indicates that the initial appear-
ance of deletion mutants is a relatively rare event. Thus, if
the size of the sample used for propagation of the replica-
tion-competent vector stock is kept sufficiently small that
it does not already contain deletion versions, then the
probability of their formation remains low, and they will
less likely become dominant in the population.
The typical error rate for replicases of RNA viruses is esti-
mated to be as high as 1 error per 10,000 bases. Taking
into account that RNA replication consists of negative-
strand synthesis followed by positive-strand synthesis,
and that, with a low moi, this cycle is repeated more than
once, one could expect four or more changes per 10,000
bases during replication in a single cell. Thus, under the
conditions used for vector propagation (moi 0.1), the
~1000-bp SG promoter d1EGFP insert would likely
acquire more than one point mutation during five pas-
sages of the stock. Therefore, at least in part, the loss of
functional d1EGFP expression in P4 and P5 stocks may be
caused by accidental point mutations formed by RNA rep-
licase. The speed of functional inactivation of any specific
protein of interest depends on its size and sensitivity to
miss-sense mutations, but it is doubtful that any expres-
sion vector based on RNA viruses (with the exception of
coronaviruses, which have a proofreading-like function
[50]) can be propagated more than 5–10 times under low
moi conditions.Virology Journal 2009, 6:33 http://www.virologyj.com/content/6/1/33
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In a number of studies, dedicated to the construction of
replication-competent vectors, the superior stability of
novel vectors has been claimed. However, the stability of
different replication-competent alphavirus vectors can
only be compared if they have been propagated and ana-
lysed under similar conditions. Among vectors that have
been propagated and analysed in the same manner as in
the present study, the most stable ones are CHIKV-LR
5'GFP [23] and SFV4(3H)-eGFP [19]; both of these pro-
duce nearly 95% EGFP-positive plaques after five passages
in BHK-21 cells. Thus, SFV4-T37/17-d1EGFP, which was
the most stable replication-competent vector constructed
in the present study (Table 1), also represents a vector
with excellent genetic stability.
The use of IRES elements was considered as an alternative
for SG promoter insertion, since it avoids duplication of
viral sequences and allows early protein expression
directly from genomic RNA of vectors. IRES elements and
the d1EGFP sequence placed under their control were well
tolerated and maintained in terminal vectors (Figure 5),
but in all cases, the IRES elements themselves were non-
functional, regardless of their origin (EMCV IRES or CR
IRES) and insertion site. In contrast, EMCV IRES inserted
into the VEEV genome is functional and can be used to
direct synthesis of the structural proteins of this virus [32].
IRES-containing VEEV also has an interesting functional
defect: despite effective replication and structural protein
expression, it produces very few infectious virions. This
defect is compensated by mutations in nsP2 but the mech-
anism of compensation is not fully understood [32]. Cur-
rently, it is unclear if the selection for compensatory
mutations can be used to activate the IRES-derived expres-
sion in the case of replication-competent SFV4-based vec-
tors. An alternative approach, the removal of the hairpin
structure of SG mRNA, which can functionally or structur-
ally interfere with the activity of IRES elements, failed to
restore IRES activity. Thus, in contrast to the alphavirus-
derived VLP or DNA-RNA layered vectors, IRES elements
did not function in SFV4-derived replication-competent
vectors. The mechanisms responsible for this phenome-
non, as well as those responsible for differences between
SFV4 and VEEV-based systems remain unknown.
The infectivity of naked genomic RNA simplifies the con-
struction of highly representative expression libraries
based on an alphavirus VLP system. However, such librar-
ies have several problems. First, the suicidal nature of
these VLP-system vectors does not allow propagation of
the library. To some extent, this problem can be overcome
by the use of packaging cell lines [51] or three-component
vector systems described for SINV vectors [52]. Second, in
general, these systems do not produce infectious progeny
in cells used for functional analysis of expressed proteins.
Consequently, the vector's genetic material must be
extracted from selected cells and analysed. If functional
analysis requires multiple cycles of selection, it becomes
time consuming and complicated. Therefore replication-
competent vectors, which can be propagated and produce
infectious progeny in any infected cell, greatly simplify the
analysis and selection of viruses during multiple cycles of
analysis. On the other hand, specific problems such as sta-
bility and the packaging limit for such a vector are typical
for replication-competent vector-based libraries. Thus, the
approach that allows easy conversion of VLP-based
expression libraries to replication-competent vector
libraries (Figure 6A) and combines benefits of both sys-
tems, may be useful. The same approach can also be used
for conversion of any single VLP-type vector into a replica-
tion-competent vector.
The single-step in vitro ligation/transcription procedure
offers an alternative for constructing VLP-based libraries
and their subsequent conversion to replication-compe-
tent vector libraries. In the case of middle vectors, it is
required that three fragments, which represent the repli-
case, insert (library) and structural part, are joined in one
reaction. The efficiency of this process was much lower
(data not shown) than for terminal vectors, for which
only two fragments had to be joined (Figure 6B). In the
latter case, the second fragment should, however, contain
sequences required for alphavirus replication. In the
present study, this was achieved by the use of plasmid vec-
tors that contained a 3'-UTR of SFV4 followed by a
poly(A) tract. This may not have been necessary since the
essential 3'-elements required for replication of the
alphavirus genome consist only of 19 conserved 3'-resi-
dues and a poly(A) tract that contains 12 A residues [53].
Such 31-base sequences can be included in primers used
for library generation. pSFV4-T26/20, pSFV4-T37/17 or
pSFV4-T99/45 can be used as vectors for the library. Even
the use of pSFV4-T21/5 can be envisaged for cases where
very low expression levels of inserted genes are required.
The in vitro ligation/transcription procedure was efficient
and allowed us to obtain highly representative libraries
that contained hundreds of thousands of different viral
clones (or more, if more material was used for ligation/
transcription, or if the procedure of joining two fragments
were further optimised). It was also found that expression
cassettes of other types of SFV4-based vectors such as
SFV4(3H)-eGFP or SFV4-steGFP [19] could be combined
with any terminal vector that allowed expression of two
foreign proteins (data not shown). For example, the first
cassette can be used for expressing a marker, which allows
identification/purification of infected cells (or for express-
ing a reporter to provide an internal standard), while the
duplicated SG promoter of the terminal vector may be
used for expression of the library. The downside of this
approach is the reduced capacity of such vectors
(decreased by the size of the first expression cassette), andVirology Journal 2009, 6:33 http://www.virologyj.com/content/6/1/33
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the possibly reduced genetic stability caused by the large
size of the genome.
Conclusion
The data obtained in this study allow us to conclude that
the minimal functional SG promoter of SFV4 is organised
differently from that of SINV and other alphaviruses. The
presence of a G residue at the -1 position of the SG pro-
moter of SFV4 is not compensated by changes in virus-
encoded proteins, as previously hypothesised. Instead, the
minimal SG promoter of SFV4 is longer than those of
other alphaviruses and includes residues located in the -
22 to -26 region. The presence of residues located
upstream of position -27 and possibly, residues located
downstream of position +5, has a smaller effect on the
activity of the SG promoter of SFV4 than that of SINV [27].
It was found that when constructed vectors were unable to
express viral structural proteins at the level required for
virion formation, genetic rearrangements that led to resto-
ration of such expression had taken place in initially trans-
fected cells. In total, five vectors analysed in the present
study suffered from this problem. In all of these vectors,
extreme instability of their genomes was observed: the
inserted sequences were lost and expression of structural
proteins was switched back to the native SG promoter. In
contrast, all vectors capable of structural protein expres-
sion formed essentially homogeneous stocks in initially
transfected cells.
By duplicating the SG promoter sequence, six replication-
competent SFV4-based vectors, which were capable of vir-
ion formation and expression of inserted markers, were
obtained. The genetic stability of these vectors, as well as
RNA synthesis, protein expression, virus rescue and
growth kinetics, was analysed and compared with data
obtained for eight defective vectors. These data allow us to
conclude that the loss of ability to express functional
markers by replication-competent vectors is mainly
caused by the loss of inserted sequences. The loss of activ-
ity of inserted proteins, caused by accumulation of point
mutations that result from the lack of proofreading func-
tion of RNA replicase, may be important only for the most
stable replication-competent vectors.
The growth advantage of genomes with deletions over the
original genomes of the replication-competent vectors is
the main driving force for the elimination of inserted
sequences. When the loss of inserted sequences is attrib-
uted to the homologous copy-choice recombination
between native and inserted sequences, reduced genetic
stability of the vector is observed. This may be a conse-
quence of higher efficiency of homologous recombina-
tion compared to the mechanisms of deletion by non-
homologous recombination, or it may result from the fact
that homologous recombination reverts the vector to the
wild-type SFV4 (which has the biggest growth advantages
over the vectors with inserts). These tendencies should be
taken into account for design of stable and efficient repli-
cation-competent vectors of SFV4 and for selection of con-
ditions for their propagation.
Comparison of reported properties of replication-compe-
tent vectors of different designs and origin reveals a con-
tradictory picture. In part, these contradictions may be
attributed to the different methods used for the analysis of
constructed vectors; however, it is likely that the number
of discrepancies reflects unique properties of individual
viruses and their isolates (exemplified by the unique struc-
ture of the SG promoter of SFV4). Therefore designs that
work efficiently for one group of alphavirus-based vectors
may not necessarily do so in others. Furthermore, the
designs used for the replicon (VLP or DNA-RNA layered)
vectors may not work in the same way for replication-
competent vectors (exemplified by the different activities
of IRES elements).
Replication-competent vectors, including those of SFV4,
represent tools for cloning and functional analysis of
expression libraries. In cases where such libraries cannot
be created by obtaining a plasmid library and subsequent
rescue of replication-competent vectors, the method of in
vitro ligation/transcription developed in the present study
can be used. The method can also be used for conversion
of VLP-type replicon-vector libraries to replication-com-
petent vector libraries, and may use the benefits of both
types of vectors.
Methods
Cells and medium
BHK-21 cells were grown in Glasgow's Minimal Essential
Medium (GMEM) that contained 5% foetal calf serum
(FCS), 0.3% tryptose phosphate broth, 0.1 U/mL penicil-
lin and 0.1 μg/mL streptomycin in an incubator at 37°C
and 5% CO2.
Viral sequences and clones
For construction of replication-competent vectors of
SFV4, the following plasmids that contained cDNA of
SFV4 were used: pSP6-SFV4 [46], pSFV1, pHelper1 [3] and
pCMV-SFV4 [13]. The sequences of EMCV IRES (pIRES2-
EGFP; BD Clontech) and the 148-bp CR IRES [54] ele-
ments, and their positioning with respect to the initiation
codon were identical to the previously described SFV VLP
replicon vectors [29].
Cloning, PCR and in vitro mutagenesis
Standard cloning procedures were used for construction
of modified replicon-, helper- and replication-competent
vector cDNAs. The oligonucleotide primers were obtainedVirology Journal 2009, 6:33 http://www.virologyj.com/content/6/1/33
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from Sigma-Proligo. PCR-based mutagenesis reaction and
PCR amplifications were performed by use of Phusion
High-Fidelity DNA polymerase (Finnzymes). All DNA
sequences, resulting from PCR reactions, in vitro mutagen-
esis or insertions of oligonucleotide duplexes, were veri-
fied by sequencing. Sequences of all clones are available
from the authors upon request.
Construction of SFV4 terminal vectors with inserted 
d1EGFP marker
To construct replication-competent SFV4 vectors that con-
tained a duplicated SG promoter inserted in a 3'-UTR of
SFV4, a polylinker with the sequence GGGCCCG-
GGGGATCC was inserted in pSP6-SFV4, immediately
downstream of the terminator codon of the E1 gene. The
resulting plasmid was designated pSP6-SFV4-PL. The full-
length (-99/+45) SG promoter was PCR-amplified using
primers that contained ApaI (upstream) and BamH1
(downstream) recognition sites at the 5' ends, and the
sequences of minimal (-21/+5) and medium-sized (-26/
+20 and -37/+17) SG promoters were constructed from
oligonucleotide duplexes. Duplicated SG-promoter
sequences were inserted into the ApaI/BamHI-digested
pSP6-SFV4-PL to obtain plasmids designated pSFV4-T21/
5, pSFV4-T26/20, pSFV4-T37/17 and pSFV-T99/45. The
ORF of d1EGFP (BD-Clontech) was fused to the 3'-UTR of
SFV4 (including poly(A)48  sequence), PCR-amplified
using primers 5'-CGGGATCCGATATGGTGAGCAAG-
GGCGAGGAGCTGTT-3' (start codon of d1EGFP in bold)
and 5'-CGACTAGT(T)48GGAAATATT-3', and cloned into
BamH1/SpeI-digested pSFV4-T21/5, pSFV4-T26/20,
pSFV4-T37/17 and pSFV4-T99/45. The resulting plasmids
were designated pSFV4-T21/5-d1EGFP, pSFV4-T26/20-
d1EGFP, pSFV4-T37/17-d1EGFP and pSFV4-T99/45-
d1EGFP.
To construct vectors that contained IRES elements down-
stream of the region that encodes for structural proteins of
SFV4, the EMCV-IRES and the CR-IRES were first fused
with the coding sequence of d1EGFP. The obtained
sequences were PCR-amplified using primers that con-
tained ApaI (upstream) and BamHI (downstream) recog-
nition sites at the 5' ends, and inserted into the ApaI/
BamHI-digested pSFV4-PL to obtain plasmids designated
pSFV4-EMCV-d1EGFP and pSFV4-CR-d1EGFP.
Construction of SFV4 middle vectors with inserted d1EGFP 
marker
To construct replication-competent SFV4 vectors that con-
tained duplicated SG promoters inserted in intergenic
regions, a polylinker in pSFV1 was replaced by sequences
that contained recognition sites for (5' to 3') BamHI, NruI,
ClaI and ApaI, which resulted in plasmid pSFV1-PLApa.
To obtain plasmid pSFV1-PLApa-d1EGFP, the sequence
that codes for d1EGFP was cloned into pSFV1-PLApa
using BamH1 and NruI sites of the polylinker. pHelper1
was used as a template for PCR-based mutagenesis to
introduce the recognition site of ApaI at 96, 37, 26 or 21
bases upstream of the position corresponding to the 5'
end of SG mRNA. This resulted in plasmids that were des-
ignated pHelper96, pHelper37, pHelper26 and
pHelper21. The cDNA clones of replication-competent
vectors with d1EGFP markers were obtained by cloning
ApaI/SpeI restriction fragments from pHelper96,
pHelper37, pHelper26 and pHelper21 to pSFV1-PLApa-
d1EGFP vector digested with the same enzymes. The
resulting clones were designated pSFV4-d1EGFP-M96,
pSFV4-d1EGFP-M37, pSFV4-d1EGFP-M26 and pSFV4-
d1EGFP-M21.
To construct replication-competent SFV4 vectors that con-
tained IRES elements, a polylinker with the sequence
GGGCCCATGCATATACATATG (which contained recog-
nition sites for ApaI, NsiI and NdeI, nucleotides in bold
correspond to the start codon of SFV4 structural polypro-
tein) was inserted in pHelper1, and the resulting plasmid
was designated pHelperPL. The PCR-amplified fragments
of the EMCV IRES and the CR IRES were cloned into NsiI-
and NdeI-digested pHelperPL, and the resulting plasmids
were designated pHelperEMCV and pHelperCR. The
cDNA clones of replication-competent vectors with
d1EGFP markers were obtained by cloning ApaI/SpeI
restriction fragments from pHelperEMCV and pHelperCR
to pSFV1-PLApa-d1EGFP vector digested with the same
enzymes. The resulting clones were designated pSFV4-
d1EGFP-MEMCV and pSFV4-d1EGFP-MCR.
To destabilize the hairpin structure at the RNA region that
encoded for the 31 N-terminal amino acid residues of
SFV4 capsid protein, 24 silent mutations were introduced
into the corresponding region of pHelperPL, and the
resulting plasmid was designated pHelperPL-HRP-. The
PCR-amplified fragments of EMCV IRES and CR IRES
were cloned into pHelperPL-HRP- as described above, and
the resulting plasmids were designated pHelperEMCV-
HRP- and pHelperCR-HRP-. Construction of plasmids that
contained cDNAs of the corresponding replication-com-
petent SFV4 vectors using ApaI/SpeI restriction fragments
from pHelperEMCV-HRP-  and pHelperCR-HRP-  and
pSFV1-PLApa-d1EGFP vector was not successful, because
of the increased instability of the resulting plasmids in E.
coli. To overcome this obstacle, all the essential elements
of these replication-competent vectors, including the
modified polylinker with an inserted d1EGFP marker,
IRES element and start region for the structural region
with the mutated hairpin element were transferred to
pCMV-SFV4 vector [13], and the resulting infectious plas-
mids were designated pCMV-SFV4-d1EGFP-MEMCV-
HRP- and pCMV-SFV4-d1EGFP-MCR-HRP-.Virology Journal 2009, 6:33 http://www.virologyj.com/content/6/1/33
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Generation of PCR fragments with randomised sequences
The template plasmid used for random libraries genera-
tion contained the coding sequence of d1EGFP, followed
by the 3'-UTR of SFV4 and poly(A) of 48 A residues. The
random library was created by PCR reaction using an
upstream (sense) primer with the sequence 5'-
CGGGATCC(N)21GATATGGTGAGCAAGGGCGAGGAG
CTGTT-3' (N is a random nucleotide, the start codon for
d1EGFP is in bold) and a downstream (antisense) primer
with the sequence 5'-CGACTAGT(T)48GGAAATATT-3'.
PCR reaction was carried out by use of Phusion High
Fidelity DNA polymerase (Finnzymes). The 5'-region of
the obtained product was sequenced to eliminate the pos-
sibility of library shifts.
In vitro ligation
The procedure for construction of replication-competent
SFV4 vectors or replication-competent SFV4 vector-based
libraries is illustrated by the following examples. The DNA
fragment obtained by SphI and ApaI digestion of pSFV1-
PLApa-d1EGFP (containing promoter for SP6 RNA
polymerase, 5'-UTR and ns part of the SFV4 genome,
native SG promoter, and cloned d1EGFP marker) was
ligated with a DNA fragment obtained by ApaI and SpeI
digestion of pHelper96 (containing duplicated 96/51 SG
promoter, structural region of SFV4 genome, and 3'-UTR
with poly(A) sequence). For library construction, the
DNA fragment obtained by SphI and BamHI digestion of
pSFV4-T37/17 (containing the promoter for SP6 RNA
polymerase, full-lenght cDNA of the SFV4 genome except
for the 3'-UTR and duplicated 37/17 SG promoter) was
ligated with a fragment obtained by BamHI digestion of
an in vitro mutagenesis product (containing a randomised
region followed by the coding sequence of d1EGFP, 3'-
UTR of SFV4 and poly(A)48 sequence). The following con-
ditions of ligation were used: 1 μg of DNA fragment that
contained cDNA for the ns region of SFV4, was ligated
with 10-fold molar excess of DNA fragment that con-
tained cDNA for the 3' regions of SFV4. Ligation was car-
ried using T4 DNA ligase (Roche) in the presence of PEG
at 12°C for 24 h. The ligation products were purified
using the PCR Purification Kit (Genomed GmbH) and
used as a template for in vitro transcription.
In vitro transcription and transfection of cells
Plasmids that contained the cDNAs of SFV4-based replica-
tion-competent vectors were linearised by SpeI digestion.
Alternatively, the products of in vitro ligation were used as
a template for transcription. Infectious transcripts were
synthesized in vitro by SP6 RNA polymerase and used for
cell transfection by electroporation as described previ-
ously [55]. For pCMV-SFV4 and replication-competent
vectors, based on this plasmid, we used the transfection
procedure described previously [13]. Primary stocks of
replication-competent SFV4 vectors or expression libraries
were collected from transfected BHK-21 cell cultures at 12
h post-transfection.
Virological methods
Titres of collected stocks were determined by standard
plaque assay. The growth curves of replication-competent
SFV4 vectors were analyzed as previously described [18].
For infectious centre assay, we used in-vitro-synthesized
RNA, obtained by ligation/transcription reaction, for elec-
troporation of 8×106 BHK-21 cells. Ten-fold dilutions of
electroporated cells were seeded in six-well tissue culture
plates that contained 1.5×106 BHK-21 cells per well. After
2 h incubation at 37°C, cells were overlaid with 2 ml of
carboxyl methyl cellulose (CMC) that contained GMEM
(2% CMC:GMEM ratio was 2:3, final concentration of
FCS was 1.2%). Plaques were stained with crystal violet
after 2 days incubation at 37°C. The stocks of replication-
competent SFV4 vectors were propagated and assayed for
stability of d1EGFP expression as described previously
[18,19].
Analysis of expression of vector-encoded proteins
BHK-21 cells (8× 106) were transfected with 10 μg of
infectious transcripts or infectious plasmids. At 12 h post-
transfection, cells were lysed with Laemmli buffer and the
vector-expressed proteins were subjected to SDS-PAGE in
12% gel (lysate from 50,000 cells was loaded on each col-
umn). Proteins were transferred to a nitrocellulose mem-
brane and probed with rabbit polyclonal antiserum
against SFV nsP1, rabbit polyclonal antiserum against SFV
capsid protein, or rabbit polyclonal antiserum against
EGFP (all prepared in-house). Western blots were visual-
ised by use of HRP-conjugated anti-rabbit antibody and
ECL Immunoblot Detection Kit (GE Healthcare). d1EGFP
expression was detected by fluorescent microscopy and
BD LSR II flow cytometry.
Virus RNA purification and Northern blot analysis
BHK-21 cells (1.5× 106) were infected at an moi of 5 with
P1 stocks of replication – competent vectors of SFV4, cells
infected SFV4 and mock-infected cells were used as con-
trols. Total RNA was purified with TRIzol reagent (Invitro-
gen). Equal amounts (10 μg) of RNA were denatured for
10 min at 65°C in formamide-formaldehyde buffer and
electrophoretically separated on 1.5% agarose gels sup-
plemented with 0.2 M formaldehyde. The separated RNAs
were transferred to Hybond-N+ membrane (Amersham
Biosciences) and UV cross-linked. Hybridization with an
RNA probe, complementary to the 3'-UTR of SFV4
genome, was performed by standard procedure. The filter
was exposed to X-ray film or analyzed by Typhoon TRIO
equipment and ImageQuant TL software (GE Healthcare).Virology Journal 2009, 6:33 http://www.virologyj.com/content/6/1/33
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